A Case Series of Omenn Syndrome in Iranian Children
Abstract
Background: Severe combined immunodeficiencies (SCIDs) are a group of disorders with variable clinical phenotypes, usually presenting with life-threatening infections. This type of immunodeficiency results from defective differentiation of hematopoietic stem cells into mature T lymphocytes leading to various identified affected genotypes of severe immunodeficiency. Omenn syndrome is an autosomal recessive immunodeficiency disorder characterized by generalized erythroderma, lymphoadenopathy, and eosinophilia. The aim of this study was to provide specific information about the clinical, immunological, and genetic characteristics in this context.
Methods: A retrospective case review was conducted at Shahid Beheshti, Children Medical Center and Azad University Hospitals of Tehran so that the patients with a previously diagnosis of Omenn syndrome, admitted between years 2016 and 2023, were selected and included in this study.
Results: Eleven patients with known Omenn syndrome were included in our study. The mean age of onset in the patients was 45 days old. Six (54.5%) were female and 5 (45.5%) were male. There was a history of parental consanguinity in 10 out of 11 studied children (91%). BCG dissemination, erythroderma, hepatosplenomegaly, lymphadenopathies, failure to thrive, recurrent infections, and gastrointestinal manifestations were more prominent. Other presentations in order of frequency were failure to thrive (90.9%), recurrent infections (63.6%), erythroderma (63%), hepatosplenomegaly (45.5%), lymphadenopathy (36.4%), and BCG dissemination (27.3%).
Conclusion: As Omenn syndrome is a type of SCID and a pediatric immunologic emergency, awareness about the various clinical manifestations of the disease among people of different ethnicities is highly essential for timely and accurate diagnosis, treatment, and family counseling.
2. Villa A, Notarangelo LD, Roifman CM. Omenn syndrome: inflammation in leaky severe combined immunodeficiency. J Allergy Clin Immunol. 2008;122(6):1082-6.
3. Tsilifis C, Spegarova JS, Good R, Griffin H, Engelhardt KR, Graham S, et al. Omenn syndrome in two infants with different hypomorphic variants in Janus kinase 3. J Clin Immunol. 2024;44(4):98.
4. Roifman CM. Severe combined immunodeficiency. In: Rich RR, editor. Clinical Immunology: Principles and Practice. Elsevier Saunders; 2013.
5. Fuchs S, Rensing-Ehl A, Pannicke U, Lorenz MR, Fisch P, Jeelall Y, et al. Omenn syndrome associated with a functional reversion due to a somatic second-site mutation in CARD11 deficiency. Blood. 2015;126(14):1658-69.
6. Somech R, et al. Reduced central tolerance in Omenn syndrome leads to immature self-reactive oligoclonal T cells. J Allergy Clin Immunol. 2009;124(4):793-800.
7. Khan U, Ahmad RU, Aslam A. An infant with Omenn syndrome: a case report. Ann Med Surg (Lond). 2022;74:103319.
8. Al Aboud A, Al Aboud K. Gilbert Omenn and his syndrome. Our Dermatol Online. 2012;3(1):55-6.
9. Hsu CC, Lee JYY, Chao SC. Omenn syndrome: a case report and review of literature. Dermatol Sin. 2011;29(2):50-4.
10. Elnour IB, Ahmed S, Halim K, Nirmala V. Omenn’s syndrome: a rare primary immunodeficiency disorder. Sultan Qaboos Univ Med J. 2007;7(2):133.
11. Zafar R, Ver Heul A, Beigelman A, Bednarski J, Bayliss SJ, Dehner LP, et al. Omenn syndrome presenting with striking erythroderma and extreme lymphocytosis in a newborn. Pediatr Dermatol. 2017;34(1):e37-9.
12. Giliani S, Bonfim C, De Saint Basile G, Lanzi G, Brousse N, Koliski A, et al. Omenn syndrome in an infant with IL7RA gene mutation. J Pediatr. 2006;148(2):272-4.
13. Mazzucchelli RI, Riva A, Durum SK. The human IL-7 receptor gene: deletions, polymorphisms and mutations. Semin Immunol. 2012;24(4):225-33.
| Files | ||
| Issue | Vol 9, No 1 (2026) | |
| Section | Original Article | |
| DOI | https://doi.org/10.18502/igj.v9i1.21881 | |
| Keywords | ||
| Omenn Syndrome Primary Immunodeficiency Severe Combined Immunodeficiency SCID | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |

